Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-06-05

Clinical Trial Update: Aspirin and Thienopyridine Resistance in Peripheral Arterial Disease

View source ↗

Summary

The clinical trial on aspirin and thienopyridine resistance in peripheral arterial disease has completed, according to the registry update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)
  • CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: University of California, Davis | Conditions: Peripheral Arterial Disease, Clopidogrel, Poor Metabolism of | Status: COMPLETED